Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Oct;30(4):644–647. doi: 10.1111/j.1365-2125.1990.tb03828.x

Binding studies of platelet alpha 2- and lymphocyte beta 2-adrenoceptors in patients with cirrhosis.

A J MacGilchrist 1, N M Deighton 1, C A Hamilton 1, J L Reid 1
PMCID: PMC1368260  PMID: 1963313

Abstract

Radioligand binding studies were performed on 10 patients with cirrhosis and 10 healthy subjects. Bmax and KD of platelet alpha 2-adrenoceptors, studied using [3H]-yohimbine, were similar in both groups (Bmax 24.9 vs 22.1 fmol/10(9) platelets, P = 0.47; KD 4.6 vs 5.5 nmol 1-1, P = 0.56). Bmax and KD of lymphocyte beta 2-adrenoceptors, studied using [125I]-iodocyanopindolol, were also similar in both groups (Bmax 24.0 vs 27.2 fmol mg-1 protein, P = 0.55; KD 49.6 vs 55.3 pmol 1-1, P = 0.65). In this model there is no evidence of adrenoceptor down-regulation in cirrhosis despite the increased sympathetic activity in this condition.

Full text

PDF
645

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons R. D., Nies A. S., Gerber J. G., Molinoff P. B. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther. 1983 Jan;224(1):1–6. [PubMed] [Google Scholar]
  2. Bernardi M., Trevisani F., Santini C., Ligabue A., Capelli M., Gasbarrini G. Impairment of blood pressure control in patients with liver cirrhosis during tilting: study on adrenergic and renin-angiotensin systems. Digestion. 1982;25(2):124–130. doi: 10.1159/000198820. [DOI] [PubMed] [Google Scholar]
  3. Brodde O. E. Endogenous and exogenous regulation of human alpha- and beta-adrenergic receptors. J Recept Res. 1983;3(1-2):151–162. doi: 10.3109/10799898309041930. [DOI] [PubMed] [Google Scholar]
  4. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  5. Deighton N. M., Brown A. D., Hamilton C. A., Reid J. L. Regulation of adrenergic receptor number following chronic noradrenaline infusion in the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov;338(5):517–522. doi: 10.1007/BF00179323. [DOI] [PubMed] [Google Scholar]
  6. Gerbes A. L., Remien J., Jüngst D., Sauerbruch T., Paumgartner G. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet. 1986 Jun 21;1(8495):1409–1411. doi: 10.1016/s0140-6736(86)91556-4. [DOI] [PubMed] [Google Scholar]
  7. Henriksen J. H., Christensen N. J., Ring-Larsen H. Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics. Clin Physiol. 1981 Jun;1(3):293–304. doi: 10.1111/j.1475-097x.1981.tb00898.x. [DOI] [PubMed] [Google Scholar]
  8. Jones C. R., Giembcyz M., Hamilton C. A., Rodger I. W., Whyte K., Deighton N., Elliott H. L., Reid J. L. Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man. Clin Sci (Lond) 1986 Feb;70(2):147–153. doi: 10.1042/cs0700147. [DOI] [PubMed] [Google Scholar]
  9. Jones C. R., Hamilton C. A., Whyte K. F., Elliott H. L., Reid J. L. Acute and chronic regulation of alpha 2-adrenoceptor number and function in man. Clin Sci (Lond) 1985;68 (Suppl 10):129s–132s. doi: 10.1042/cs068s129. [DOI] [PubMed] [Google Scholar]
  10. Lunzer M. R., Newman S. P., Bernard A. G., Manghani K. K., Sherlock S. P., Ginsburg J. Impaired cardiovascular responsiveness in liver disease. Lancet. 1975 Aug 30;2(7931):382–385. doi: 10.1016/s0140-6736(75)92896-2. [DOI] [PubMed] [Google Scholar]
  11. Lunzer M., Newman S. P., Sherlock S. Skeletal muscle blood flow and neurovascular reactivity in liver disease. Gut. 1973 May;14(5):354–359. doi: 10.1136/gut.14.5.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MURRAY J. F., DAWSON A. M., SHERLOCK S. Circulatory changes in chronic liver disease. Am J Med. 1958 Mar;24(3):358–367. doi: 10.1016/0002-9343(58)90322-x. [DOI] [PubMed] [Google Scholar]
  13. Middeke M., Remien J., Kirzinger S., Holzgreve H. Adrenergic hyposensitivity during long-term diuretic therapy--a possible explanation for the antihypertensive effect of diuretics? Eur J Pharmacol. 1985 Mar 12;109(3):401–403. doi: 10.1016/0014-2999(85)90402-9. [DOI] [PubMed] [Google Scholar]
  14. Motulsky H. J., Shattil S. J., Insel P. A. Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine. Biochem Biophys Res Commun. 1980 Dec 31;97(4):1562–1570. doi: 10.1016/s0006-291x(80)80044-1. [DOI] [PubMed] [Google Scholar]
  15. Murray B. M., Paller M. S. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action. Circ Res. 1985 Sep;57(3):424–431. doi: 10.1161/01.res.57.3.424. [DOI] [PubMed] [Google Scholar]
  16. Nicholls K. M., Shapiro M. D., Van Putten V. J., Kluge R., Chung H. M., Bichet D. G., Schrier R. W. Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion. Circ Res. 1985 Mar;56(3):457–461. doi: 10.1161/01.res.56.3.457. [DOI] [PubMed] [Google Scholar]
  17. Pfeifer M. A., Ward K., Malpass T., Stratton J., Halter J., Evans M., Beiter H., Harker L. A., Porte D., Jr Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine. J Clin Invest. 1984 Sep;74(3):1063–1072. doi: 10.1172/JCI111473. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES